CoChat

Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells.

Open access
Bug, Gesine, Gül, Hilal, Schwarz, Kerstin, Pfeifer, Heike, Kampfmann, Manuela, Zheng, Xiaomin, Beissert, Tim, Boehrer, Simone, Hoelzer, Dieter, Ottmann, Oliver Gerhard, Ruthardt, Martin · 2005 · Cancer Research

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Histone deacetylase inhibitors have attracted considerable attention because of their ability to overcome the differentiation block in leukemic blasts, an effect achieved either alone or in combination with differentiating agents, such as all-trans retinoic acid. We have previously reported favorable effects of the potent histone deacetylase inhibitor valproic acid in combination with all-trans retinoic acid in patients with advanced acute myeloid leukemia leading to blast cell reduction and improvement of hemoglobin. These effects were accompanied by hypergranulocytosis most likely due to an enhancement of nonleukemic myelopoiesis and the suppression of malignant hematopoiesis rather than enforced differentiation of the leukemic cells. These data prompted us to investigate the effect of valproic acid on normal hematopoietic stem cells (HSC). Here we show that valproic acid increases both proliferation and self-renewal of HSC. It accelerates cell cycle progression of HSC accompanied by a down-regulation of p21(cip-1/waf-1). Furthermore, valproic acid inhibits GSK3beta by phosphorylation on Ser9 accompanied by an activation of the Wnt signaling pathway as well as by an up-regulation of HoxB4, a target gene of Wnt signaling. Both are known to directly stimulate the proliferation of HSC and to expand the HSC pool. In summary, we here show that valproic acid, known to induce differentiation or apoptosis in leukemic blasts, stimulates the proliferation of normal HSC, an effect with a potential effect on its future role in the treatment of acute myeloid leukemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-04-3011

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 1

  1. Bug G, Romanski A, Guel H, Hoelzer D, Ottmann OG, Ruthardt M. CG1521 and CG1255: two new histone- deacetylase inhibitors for the differentiation therapy of acute myeloid leukemia. Blood 2002;100:2122a.

Cited by

See all 195

Metadata

Authors
Bug, G., Gül, H., Schwarz, K., Pfeifer, H., Kampfmann, M., Zheng, X., Beissert, T., Boehrer, S., Hoelzer, D., Ottmann, O. G., & Ruthardt, M.
Affiliations
  • Goethe University Frankfurt (DE)
  • Medizinische Klinik II/Abteilung Hämatologie, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt, Germany
Venue
Cancer Research
Published
2005-04-01
Volume
65
Issue
7
Pages
2537-2541
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2100476572
Cited by
195
References
17
Citations by year
2026: 2 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 4 · 2020: 3 · 2019: 6 · 2018: 7 · 2017: 11 · 2016: 4 · 2015: 13 · 2014: 10 · 2013: 7 · 2012: 21
FWCI
8.57
Type
journal article
Language
en
Open access
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
Keywords
valproic acid, hematopoietic stem cells, stem cell self-renewal, stem cell proliferation, histone deacetylase inhibitors, acute myeloid leukemia, Wnt signaling, GSK3β, HOXB4, p21, cell cycle progression, all-trans retinoic acid
MeSH terms
Glycogen Synthase Kinase 3 beta, Animals, Cell Cycle, Cell Differentiation, Enzyme Activation, Hematopoietic Stem Cells, Humans, Mice, Inbred C57BL, Transcription Factors, Tretinoin, Valproic Acid, Signal Transduction, Down-Regulation, Up-Regulation, Homeodomain Proteins, Cell Cycle Proteins, Antigens, CD34, Glycogen Synthase Kinase 3, Cell Proliferation, Cyclin-Dependent Kinase Inhibitor p21, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. https://app.cochat.ai/papers/10.1158/0008-5472.can-04-3011
The paper
Bug, G., Gül, H., Schwarz, K., Pfeifer, H., Kampfmann, M., Zheng, X., Beissert, T., Boehrer, S., Hoelzer, D., Ottmann, O. G., & Ruthardt, M. (2005). Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Research. https://doi.org/10.1158/0008-5472.can-04-3011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.